AIHealthcare

Thyme Care is a Nashville-based oncology healthcare company founded in 2020 by Robin Shah and Bobby Green, MD. It provides value-based cancer care navigation and care-management services through virtual clinical teams, technology, data analytics, and partnerships with health plans, employers, oncologists, and risk-bearing providers. Its platform supports patients throughout the cancer journey, helps care teams identify risks and care gaps, and is designed to improve outcomes while reducing total cost of care. Thyme Care publicly describes artificial intelligence as an important component of its technology infrastructure, including workflow automation, clinical and claims-data synthesis, risk estimation, documentation support, and next-step recommendations. The company reports nationwide reach and a network of more than 1,000 oncologists; third-party and company-reported figures indicate access to more than 8 million people as of 2025 and more than 10.5 million as of 2026. Its market position is that of a scaled, privately held value-based oncology platform rather than a pure software vendor, with strategic participation from major payers, employers, health systems, and healthcare investors. The company reported reaching unicorn status after its 2025 Series D and was named to the 2026 CNBC Disruptor 50 list.